Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Immunotech Biopharm Ltd ( (HK:6978) ) has provided an update.
Immunotech Biopharm Ltd has announced the postponement of its board meeting initially scheduled for March 28, 2025, to March 31, 2025. This delay is due to the need for additional time to finalize the company’s annual results for the year ending December 31, 2024, which could impact the company’s reporting schedule and stakeholder expectations.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It focuses on the development and commercialization of innovative therapies, likely targeting various medical conditions.
YTD Price Performance: 83.48%
Average Trading Volume: 708,350
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.17B
See more data about 6978 stock on TipRanks’ Stock Analysis page.